A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

NCT00569972 ·Status: COMPLETED ·Phase: PHASE2

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

NCT00666575 ·Status: COMPLETED ·Phase: PHASE3

An Exploratory Study of NBI-34060 Capsules and Next Day Functioning

NCT00525941 ·Status: WITHDRAWN ·Phase: PHASE3

To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia

NCT00426816 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of EVT 201 to Treat Insomnia

NCT00380003 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3

A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)

NCT00506389 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep

NCT00655369 ·Status: COMPLETED ·Phase: PHASE2

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

NCT00266357 ·Status: TERMINATED ·Phase: PHASE2

Characteristics of Sleep Patterns in Young Adults With and Without Insomnia

NCT00177216 ·Status: COMPLETED ·Phase: PHASE4

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

NCT00209950 ·Status: COMPLETED ·Phase: PHASE3

Testing the Nocturnal Sleep Latency Profile in Primary Insomnia

NCT00167375 ·Status: COMPLETED

A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia

NCT00748592 ·Status: WITHDRAWN ·Phase: PHASE2

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

NCT00209937 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

NCT00659100 ·Status: COMPLETED ·Phase: PHASE3

A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)

NCT00631657 ·Status: COMPLETED ·Phase: PHASE3

Paroxetine in the Treatment of Chronic Primary Insomnia

NCT00178048 ·Status: COMPLETED ·Phase: PHASE4

Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)

NCT00482612 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)

NCT00561821 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness

NCT00594022 ·Status: COMPLETED ·Phase: NA

Appraising Clinical Trial Experiences of Patients With Insomnia

NCT05978271 ·Status: NOT_YET_RECRUITING

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

NCT03331042 ·Status: COMPLETED ·Phase: PHASE3

Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder

NCT06279286 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

NCT00094627 ·Status: COMPLETED ·Phase: PHASE3